Clinical Trial Update: PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 study evaluating a PCSK9 inhibitor for intracranial atherosclerosis-related acute ischemic stroke is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Intracranial Atherosclerosis
• Stroke

Drugs mentioned

• PCSK9 inhibitor (PCSK9 inhibitor)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Acute Ischemic Stroke AIS, Intracranial Atherosclerosis ICAS | Phase 4 | Status: NOT_YET_RECRUITING